SCHEMBL20427062

SCHEMBL20427062

c1ccc(-n2ccc3c2ccc2c4ccc5ccccc5c4n(-c4cccc(-c5ccncc5)n4)c23)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ CYP2C9 P11712 3/20 0.34
▸ CYP1A2 P05177 3/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ CYP2D6 P10635 2/20 0.34
▸ CYP2C19 P33261 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ AR P10275 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ DYRK1A Q13627 1/20 0.34
▸ MAPK9 P45984 1/20 0.33
▸ MAPK10 P53779 1/20 0.33
▸ POLB P06746 2/20 0.32
▸ THRB P10828 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20427061 0.95 COMT (0.34) RAB9AKMT2ACOMT
SCHEMBL16357390 0.90 MAPT (0.35) MAPTKDM4ECYP2C9CYP1A2CYP3A4
SCHEMBL16357425 0.84 KDM4E (0.36) MAPTKDM4ERAB9APOLBKMT2A
SCHEMBL20426299 0.84 KDM4E (0.36) MAPTKDM4EALDH1A1CYP2C9CYP1A2
SCHEMBL15617238 0.83 DYRK1A (0.34) MAPTKDM4EALDH1A1HPGDCYP2C9
SCHEMBL20427072 0.83 MAPT (0.38) MAPTDYRK1AMAPK9MAPK10
SCHEMBL15802198 0.82 KDM4E (0.36) MAPTKDM4ERAB9APOLBKMT2A
SCHEMBL16357345 0.81 MAPT (0.36) MAPTKDM4EALDH1A1HPGDCYP2C9
SCHEMBL16357517 0.81 MAPT (0.39) MAPTALDH1A1NPC1RAB9ADYRK1A
SCHEMBL15857461 0.80 MAPT (0.37) MAPTKDM4EALDH1A1CYP2C9CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same IDO1, IDO2, KYNU MAPT 459/4885KDM4E 1494/4885ALDH1A1 458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback